Skip to main content
. 2008 Mar 11;336(7648):813–816. doi: 10.1136/bmj.39507.551644.BE

Table 1.

 Characteristics of cases with atrial fibrillation and flutter and population controls

Characteristic No (%) of cases (n=13 586) No (%) of controls (n=68 054)
Bisphosphonate exposure
Current 435 (3.2) 1958 (2.9)
Former 289 (2.1) 1180 (1.7)
Never 12 862 (94.7) 64 781 (95.4)
Current users:
 New 32 (0.2) 156 (0.2)
 Continuing 403 (3.0) 1802 (2.6)
No of prescriptions for bisphosphonates, current users:
 1-3 54 (0.4) 240 (0.4)
 4-9 144 (1.1) 606 (0.9)
 ≥10 238 (1.8) 1112 (1.6)
Covariates
Age (years):
 ≤70 3573 (26.3) 17 834 (26.3)
 71-80 4579 (33.7) 23 034 (33.7)
 >80 5434 (40.0) 27 141 (39.9)
Previous hospital diagnoses:
 Cardiovascular disease 3582 (26.4) 9121 (13.4)
 Diabetes 904 (6.7) 2679 (3.9)
 Renal failure 211 (1.6) 342 (0.5)
 Pulmonary disease 2270 (16.7) 6816 (10.0)
 Cancer 1908 (14.0) 7827 (11.5)
 Liver disease 1261 (9.3) 3606 (5.3)
 Hyperthyroidism 842 (6.2) 2574 (3.8)
 Osteoporosis 1209 (8.9) 5329 (7.8)
 Hip or wrist fracture 2096 (15.4) 9472 (13.9)
Current use of drugs (prescription):
 Cardiovascular 11 087 (81.6) 41 816 (61.4)
 Antithyroid 788 (5.8) 2273 (3.3)
 Thyroid replacement 897 (6.6) 4128 (6.1)
 Hormone replacement 2717 (20.0) 14 198 (20.9)
 Oral glucocorticoids 1783 (13.1) 6030 (8.9)
 Respiratory 2923 (21.5) 9913 (14.6)
Hospital diagnosis and current use of drugs (prescription):
 Alcoholism 131 (0.9) 386 (0.6)
Hospital diagnosis concurrent with index date:
 Acute alcohol intoxication 44 (0.3) 115 (0.2)